Current Developments and Innovations in Early Detection and Subsequent Treatment of Cancer
Bibliographic record
Abstract
Objective: The study aimed to identify key trends in modern oncology by analysing developments and innovations in early cancer diagnosis and treatment methods. Using a comparative analysis of scientific and healthcare systems in Albania, Bulgaria, Kyrgyzstan, and Uzbekistan, the study examined innovative diagnostic approaches such as liquid biopsy, biomarker discovery, genetic testing, advanced imaging techniques, and artificial intelligence algorithms. Methods: For treatment, it highlighted immunotherapy, personalised medicine, cellular, targeted, and combination therapies, as well as the development of radiopharmaceuticals and 3D modelling for surgical planning. Results: Key findings revealed that the lack of economic support for research is the primary barrier to innovation in all four countries. Bulgaria, benefiting from European Union membership, demonstrated the highest potential for advancing oncology due to its stronger scientific, technical, regulatory, and social indicators. In contrast, Albania's transition economy and Kyrgyzstan’s social and geographical challenges significantly hinder progress. The findings underline the need for enhanced economic investment, international cooperation, and regulatory support to address disparities and foster the implementation of innovative oncology practices globally. Conclusion: This regional analysis provides insights into how tailored approaches can bridge the gap between low- and high-income countries in advancing cancer care.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.007 | 0.012 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.003 | 0.004 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.004 | 0.003 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.004 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".